New evidence for the cardiovascular benefits of long chain omega-3 fatty acids

Current Atherosclerosis Reports

Volumn 9, Issue 6, 2007, Pages 434-440

  Hansen, Susan N ^a   Harris, William S ^b  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; DIOXIN; DOCOSAHEXAENOIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID; LINOLENIC ACID; LINSEED OIL; LIPID; LONG CHAIN FATTY ACID; MERCURY; OLIVE OIL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; POLYCHLORINATED BIPHENYL; PRAVASTATIN; SIMVASTATIN;

BLEEDING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CARDIOVASCULAR SURGERY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DEATH; DIET SUPPLEMENTATION; ERYTHROCYTE MEMBRANE; FISH; FOOD CONTAMINATION; FOOD INTAKE; GASTROINTESTINAL DISEASE; HEART INFARCTION; HEART PROTECTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; JAPAN; JAPANESE; LIPID COMPOSITION; LOW DRUG DOSE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL RESEARCH; MONOTHERAPY; PATIENT COMPLIANCE; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; REVIEW; RISK BENEFIT ANALYSIS; RISK REDUCTION; SALMON; SECONDARY PREVENTION; SKIN DISEASE; SUDDEN DEATH; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS;

ANIMALS; CARDIOTONIC AGENTS; CARDIOVASCULAR DISEASES; DRUG THERAPY, COMBINATION; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FISHES; HEART; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MYOCARDIUM; NUTRITIONAL SCIENCES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT;

EID: 38149140045     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-007-0058-8     Document Type: Review

References (25)

1. Robinson JG, Stone NJ: Antiatherosclerotic and antithrombotic effects of omega-3 fatty acids. Am J Cardiol 2006, 98:39i-49i.
2. Reiffel JA, McDonald A: Antiarrhythmic effects of omega-3 fatty acids. Am J Cardiol 2006, 98:50i-60i.
3. Jacobson TA: Secondary prevention of coronary artery disease with omega-3 fatty acids. Am J Cardiol 2006, 98:61i-70i.
4. Harris WS, Bulchandani D: Why do omega-3 fatty acids lower serum triglycerides? Curr Opin Lipidol 2006, 17:387-393.
5. Davidson MH: Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. Am J Cardiol 2006, 98:27i-33i.
6. Calder PC: n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006, 83:1505S-1519S.
7. Ma DW, Seo J, Switzer KC, et al.: n-3 PUFA and membrane microdomains: a new frontier in bioactive lipid research. J Nutr Biochem 2004, 15:700-706.
8. Brenna JT: Efficiency of conversion of alpha-linolenic acid to long chain n-3 fatty acids in man. Curr Opin Clin Nutr Metab Care 2002, 5:127-132.
9. Kris-Etherton PM, Harris WS, Appel LJ: Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106:2747-2757.
10. Yokoyama M, Origasa H, Matsuzaki M, et al.: Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007, 369:1090-1098.
11. Iso H, Kobayashi M, Ishihara J, et al.: Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation 2006, 113:195-202.
12. Mozaffarian D, Rimm EB: Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 2006, 296:1885-1899.
13. Yoshizawa K, Rimm EB, Morris JS, et al.: Mercury and the risk of coronary heart disease in men. N Engl J Med 2002, 347:1755-1760.
14. Hites RA, Foran JA, Carpenter DO, et al.: Global assessment of organic contaminants in farmed salmon. Science 2004, 303:226-229.
15. Cohen JT, Bellinger DC, Shaywitz RA: A quantitative analysis of prenatal methyl mercury exposure and cognitive development. Am J Prev Med 2005, 29:353-365.
16. Harris WS, Poston WC, Haddock CK: Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events. Atherosclerosis 2007, 193:1-10.
17. Harris WS, von Schacky C: The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med 2004, 39:212-220.
18. Hjelte LE, Nilsson A: Arachidonic acid and ischemic heart disease. J Nutr 2005, 135:2271-2273.
19. Horrobin DF: Commentary on the workshop statement: are we really sure that arachidonic acid and linoleic acid are bad things? Prostaglandins Leukot Essent Fatty Acids 2000, 63:145-147.
20. Wijendran V, Hayes KC: Dietary n-6 and n-3 fatty acid balance and cardiovascular health. Annu Rev Nutr 2004, 24:597-615.
21. Leaf A, Kang JX, Xiao YF, et al.: Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation 2003, 107:2646-2652.
22. Harris WS, Sands SA, Windsor SL, et al.: Omega-3 fatty acids in cardiac biopsies from heart transplant patients: correlation with erythrocytes and response to supplementation. Circulation 2004, 110:1645-1649.
23. Metcalf RG, James MJ, Gibson RA, et al.: Effects of fish-oil supplementation on myocardial fatty acids in humans. Am J Clin Nutr 2007, 85:1222-1228.
24. Harris WS: Expert opinion: omega-3 Fatty acids and bleeding-cause for concern? Am J Cardiol 2007, 99:S44-S46.
25. US Department of Agriculture: Nutrient Data Laboratory. Available at http://www.nal.usda.gov/fnic/foodcomp/search/. Accessed June 2, 2007.